SCHEMBL4212950

SCHEMBL4212950

O=C(O)c1ccc(CCc2ccccc2)cc1NCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.59
POLB P06746 1/20 0.59
HPGD P15428 1/20 0.59
HSD17B10 Q99714 1/20 0.59
CTDSP1 Q9GZU7 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
PLK1 P53350 2/20 0.57
KDM4C Q9H3R0 5/20 0.56
KDM4E B2RXH2 2/20 0.56
KDM6B O15054 2/20 0.56
KDM4A O75164 1/20 0.56
KDM4D Q6B0I6 1/20 0.56
ASPH Q12797 1/20 0.54
RIOX2 Q8IUF8 1/20 0.54
KDM8 Q8N371 1/20 0.54
ACLY P53396 2/20 0.53
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
GAA P10253 1/20 0.51
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4221921 0.93 ALDH1A1 (0.52) ALDH1A1POLBHPGDHSD17B10CTDSP1
SCHEMBL4217232 0.88 KDM6B (0.61) ALDH1A1HPGDHSD17B10L3MBTL1KDM4C
SCHEMBL4209068 0.81 ACLY (0.77) ALDH1A1POLBHPGDHSD17B10CTDSP1
SCHEMBL1147582 0.81 KDM4C (0.56) ALDH1A1POLBHPGDHSD17B10CTDSP1
SCHEMBL7995020 0.81 PLK1 (0.67) ALDH1A1POLBHPGDHSD17B10CTDSP1
SCHEMBL9688887 0.81 ACLY (0.64) ALDH1A1POLBHPGDHSD17B10CTDSP1
SCHEMBL4223020 0.81 MEN1 (0.63) ALDH1A1ACLYMEN1KMT2AMAPT
SCHEMBL4220608 0.81 ADRA1A (0.46) ALDH1A1POLBHPGDHSD17B10CTDSP1
SCHEMBL8107946 0.80 MEN1 (0.48) KDM4CKDM4EKDM6BKDM4DASPH
SCHEMBL2691864 0.80 HSD17B10 (0.81) ALDH1A1POLBHPGDHSD17B10CTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
EP-1860098-B1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO LTD (JP) 2012-11-14 EP disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 EP disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP11, MMP3 ALDH1A1 1179/4885POLB 3706/4885HPGD 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.